The alteration by propranolol of the inotropic and bathmotropic effects of dihydro-ouabain on guinea-pig papillary muscle

  • F. Ebner
  • M. Reiter


  1. 1.

    The effect of dihydro-ouabain on the force of contraction and electrical excitability of the isolated guinea-pig papillary muscle was studied under the influence of (+)- and (±)-propranolol.

  2. 2.

    10−5 and 4×10−5 mol/l of (+)- or (±)-propranolol had a negative inotropic effect. Both the racemate and the dextro isomer reduced the inotropic effectiveness of the glycoside to the same extent. These actions were not influenced by catecholamine depletion. Even at high concentrations of dihydro-ouabain, which cannot be investigated in the absence of propranolol due to a glycoside-induced automaticity of the muscles, endogenous catecholamines were not involved in the inotropic effect.

  3. 3.

    Dihydro-ouabain had a concentration-dependent negative bathmotropic effect; 8×10−5 mol/l increased the stimulation threshold by about eight percent. The negative bathmotropic action of dihydro-ouabain was enhanced by (+)- or (±)-propranolol, in addition to their own depressant effect on electrical excitability.

  4. 4.

    Due to the combined negative bathmotropic effects, an increasing number of muscles became in-excitable at high concentrations of the glycoside in the presence of 4×10−5 mol/l (±)-propranolol but not in the presence of the same concentration of (+)-propranolol. This difference suggests that dihydro-ouabain in high concentrations releases endogenous noradrenaline which increases excitability via β-adrenoceptors.


Key words

Guinea-pig ventricular muscle Propranolol Dihydro-ouabain Inotropic effect Bathmotropic effect 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barrett, A. M., Nunn, B.: Adrenergic neuron blocking properties of (+)-propranolol and (+)-propranolol. J. Pharm. Pharmacol. 22, 806–810 (1970)Google Scholar
  2. Ebner, F., Reiter, M.: The dependence on contraction frequency of the positive inotropic effect of dihydro-ouabain. Naunyn-Schmiedeberg's Arch. Pharmacol. 300, 1–9 (1977)Google Scholar
  3. Ebner, F., Reiter, M.: The influence of (+)-propranolol on the inotropic effect of dihydro-ouabain in relation to stimulation frequency. Naunyn-Schmiedeberg's Arch. Pharmacol. 307, 105–113 (1979)Google Scholar
  4. Fawaz, G.: Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation. Br. J. Pharmacol. 29, 302–308 (1967)Google Scholar
  5. Howe, R., Shanks, R. G.: Optical isomers of propranolol. Nature 210, 1336–1338 (1966)Google Scholar
  6. Josephson, I., Sperelakis, N.: Ouabain blockade of inward slow current in cardiac muscle. J. Mol. Cell. Cardiol. 9, 409–418 (1977)Google Scholar
  7. Koch-Weser, J.: Role of norepinephrine release in the interval-strength relationship of heart muscle. J. Pharmacol. exp. Ther. 150, 184–189 (1965)Google Scholar
  8. Koch-Weser, J.: Beta-receptor blockade and myocardial effects of cardiac glycosides. Circulat. Res. 28, 109–118 (1971)Google Scholar
  9. Köhler, H. W.: On-line-Datenaufnahme und real-time-Auswertung von isometrischen Kontraktionskurven des Herzmuskels mit Hilfe eines PDP-12-Computers. Arzneim.-Forsch. (Drug Res.) 24, 815–819 (1974)Google Scholar
  10. Loubatières, A., Bouyard, P., Klein, M., Caussidier, L.: Actions inotropes cardiaques de l'ouabaïne et de divers analeptiques après blocage des récepteurs β-adrénergiques chez le chien anesthésié. C. R. Soc. Biol. (Paris) 159, 950–953 (1965)Google Scholar
  11. Méndez, C., Méndez, R.: The action of cardiac glycosides on the excitability and conduction velocity of the mammalian atrium. J. Pharmacol. exp. Ther. 121, 402–413 (1957)Google Scholar
  12. Parmley, W. W., Braunwald, E.: Comparative myocardial depressant and antiarrhythmic properties of d-propranolol, dl-propranolol and quinidine. J. Pharmacol. exp. Ther. 158, 11–21 (1967)Google Scholar
  13. Reiter, M.: Die Untersuchung inotrop wirkender Substanzen. In: festschrift 75 Jahre Hommel, pp. 480–484. Zürich: Hommel 1965Google Scholar
  14. Seifen, E.: Evidence for participation of catecholamines in cardiac action of ouabain: positive chronotropic effect. Br. J. Pharmacol. 51, 481–490 (1974a)Google Scholar
  15. Seifen, E.: Evidence for participation of catecholamines in cardiac action of ouabain. Release of catecholamines. Eur. J. Pharmacol. 26, 115–118 (1974b)Google Scholar
  16. Tanz, R. D.: The action of ouabain on cardiac muscle treated with reserpine and dichloroisoproterenol. J. Pharmacol. exp. Ther. 144, 205–213 (1964)Google Scholar
  17. Tarr, M., Luckstead, E. F., Jurewicz, P. A., Haas, H. G.: Effect of propranolol on the fast inward sodium current in frog atrial muscle. J. Pharmacol. exp. Ther. 184, 599–610 (1973)Google Scholar
  18. Van den Brink, F. G.: The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism. Eur. J. Pharmacol. 22, 270–278 (1973)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • F. Ebner
    • 1
  • M. Reiter
    • 1
  1. 1.Institut für Pharmakologie und Toxikologie der Technischen Universität MünchenMünchen 40Federal Republic of Germany

Personalised recommendations